OS Therapies (NYSEAMERICAN:OSTX) Earns Buy Rating from D. Boral Capital
OS Therapies (NYSEAMERICAN:OSTX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at D. Boral Capital in a research report issued on Monday,Benzinga reports. They currently have a $20.00 price objective on the stock. A number of other equities research analysts have also commented on the company. Zacks Research raised OS [...]